Macrophage Apoptosis in Atherogenesis
动脉粥样硬化形成中的巨噬细胞凋亡
基本信息
- 批准号:7039213
- 负责人:
- 金额:$ 37.01万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-04-01 至 2009-03-31
- 项目状态:已结题
- 来源:
- 关键词:BCL2 gene /proteinapolipoprotein Eapoptosisatherosclerotic plaquegenetically modified animalshematopoietic stem cellslaboratory mouseleukocyte activation /transformationlow density lipoprotein receptormacrophagemass spectrometrypathologic processproteolysisstem cell transplantationtransfectionvascular smooth muscle
项目摘要
DESCRIPTION (provided by applicant): Monocyte-derived macrophages are critically involved in the initiation and progression of the atherosclerotic plaque in man as well as in experimental models. Plaque rupture is thought to be the trigger event for acute coronary syndromes in man, and several mouse, models of plaque rupture have been described. Macrophages have been implicated in plaque rupture by releasing de-stabilizing proteases. Macrophage apoptosis is prominent in advanced atherosclerotic lesions, but it is controversial whether macrophage apoptosis is beneficial or detrimental. In this proposal we will examine the mechanisms and consequences of macrophage apopotosis in experimental atherogenesis. We propose that macrophage accumulation and activation in the intima contributes to smooth muscle cell death and thereby promotes plaque rupture. Therefore, we will test the primary hypothesis that macrophage apoptosis reduces intimal lesion progression and ultimately contributes to plaque stabilization. As secondary hypotheses, we also propose that Fasmediated signaling plays an important role in macrophage apoptosis and activation in atherogenesis. In Aim 1, we will identify components of the Fas signaling complex regulating activation versus apoptosis in macrophages in vitro, using isotope-coded affinity tag and tandem affinity purification with mass spectrometry. In Aim 2, we will determine the role of apoptosis proteins in macrophage activation and apoptosis in vitro. We will investigate the effect of the anti-apoptotic proteins, c-FLIP, Bcl-2, dominant-negative FADD, and p35 caspase inhibitor, on macrophage activation or apoptosis in response to Fas ligation or atherogenic stimuli. In Aim 3, we will determine the effect of blockade of macrophage apoptosis on lesion progression and plaque rupture in LDLR-/-and ApoE-/-mice. We will transduce hematopoietic stem cells (HSCs) with a novel retrbviral vector incorporating the macrophage-restricted human CD68 promoter and encoding 1 of the antiapoptotic proteins. We will then determine the effect of transplantation of HSCs transduced with a virus encoding 1 of these anti-apoptotic proteins on early and advanced lesions and plaque rupture in LDLR-/- mice. Positive results with transplantion of transduced HSC in the LDLR-/-model will be extended to lesion initiation/progression and plaque rupture in the ApoE-/-model by generating transgenic ApoE-/- mice overexpressing Bcl-2 selectively in macrophages.
描述(由申请方提供):单核细胞衍生的巨噬细胞在人类以及实验模型中与动脉粥样硬化斑块的发生和进展密切相关。斑块破裂被认为是人类急性冠状动脉综合征的触发事件,并且已经描述了几种斑块破裂的小鼠模型。巨噬细胞通过释放去稳定化蛋白酶参与斑块破裂。巨噬细胞凋亡在晚期动脉粥样硬化病变中很突出,但巨噬细胞凋亡是有益的还是有害的还存在争议。在这个建议中,我们将研究实验性动脉粥样硬化形成中巨噬细胞凋亡的机制和后果。我们认为巨噬细胞在内膜中的积聚和活化导致平滑肌细胞死亡,从而促进斑块破裂。因此,我们将检验巨噬细胞凋亡减少内膜病变进展并最终有助于斑块稳定的主要假设。作为次要假设,我们还提出Fas介导的信号转导在动脉粥样硬化形成中巨噬细胞凋亡和活化中起重要作用。在目标1中,我们将确定Fas信号复合物的组件调节激活与凋亡的巨噬细胞在体外,使用同位素编码的亲和标签和串联亲和纯化与质谱。在目标2中,我们将确定凋亡蛋白在体外巨噬细胞活化和凋亡中的作用。我们将研究抗凋亡蛋白c-FLIP、Bcl-2、显性负性FADD和p35半胱天冬酶抑制剂对Fas连接或致动脉粥样硬化刺激引起的巨噬细胞活化或凋亡的影响。在目标3中,我们将确定阻断巨噬细胞凋亡对LDLR-/-和ApoE-/-小鼠中病变进展和斑块破裂的影响。我们将用一种新的逆转录病毒载体转染造血干细胞(HSC),该载体整合了巨噬细胞限制性人CD 68启动子并编码1种抗凋亡蛋白。然后,我们将确定用编码这些抗凋亡蛋白之一的病毒转导的HSC移植对LDLR-/-小鼠中早期和晚期病变和斑块破裂的影响。通过在巨噬细胞中产生选择性过表达Bcl-2的转基因ApoE-/-小鼠,将在LDLR-/-模型中移植转导HSC的阳性结果扩展至ApoE-/-模型中的病变起始/进展和斑块破裂。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JOHN Marshall HARLAN其他文献
JOHN Marshall HARLAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JOHN Marshall HARLAN', 18)}}的其他基金
Endothelial Toll-Like Receptor-4 Signaling in Sepsis
脓毒症中的内皮 Toll 样受体 4 信号转导
- 批准号:
7031621 - 财政年份:2005
- 资助金额:
$ 37.01万 - 项目类别:
Endothelial Toll-Like Receptor-4 Signaling in Sepsis
脓毒症中的内皮 Toll 样受体 4 信号转导
- 批准号:
7418682 - 财政年份:2005
- 资助金额:
$ 37.01万 - 项目类别:
Endothelial Toll-Like Receptor-4 Signaling in Sepsis
脓毒症中的内皮 Toll 样受体 4 信号转导
- 批准号:
6923080 - 财政年份:2005
- 资助金额:
$ 37.01万 - 项目类别:
VLA-4 and VCAM-1 in Advanced Atherosclerosis
VLA-4 和 VCAM-1 在晚期动脉粥样硬化中的作用
- 批准号:
7140037 - 财政年份:2005
- 资助金额:
$ 37.01万 - 项目类别:
VLA-4 And VCAM-1 in Advanced Atherosclerosis
VLA-4 和 VCAM-1 在晚期动脉粥样硬化中的作用
- 批准号:
6858453 - 财政年份:2005
- 资助金额:
$ 37.01万 - 项目类别:
Endothelial Toll-Like Receptor-4 Signaling in Sepsis
脓毒症中的内皮 Toll 样受体 4 信号转导
- 批准号:
7226200 - 财政年份:2005
- 资助金额:
$ 37.01万 - 项目类别:
相似海外基金
Role of human apolipoprotein E isoforms in long-term effects of West Nile Virus exposure on Alzheimer's disease-related behavioral alteration, cognitive injury, neuroinflammation, and neuropathology
人类载脂蛋白 E 同工型在西尼罗河病毒暴露对阿尔茨海默病相关行为改变、认知损伤、神经炎症和神经病理学的长期影响中的作用
- 批准号:
10658408 - 财政年份:2023
- 资助金额:
$ 37.01万 - 项目类别:
A Therapeutic Role for Apolipoprotein-E in the Germ Theory of Alzheimer's Dementia
载脂蛋白-E 在阿尔茨海默氏痴呆病菌理论中的治疗作用
- 批准号:
10601779 - 财政年份:2023
- 资助金额:
$ 37.01万 - 项目类别:
Investigating how apolipoprotein E genotypes modify fatty acid metabolism
研究载脂蛋白 E 基因型如何改变脂肪酸代谢
- 批准号:
RGPIN-2018-06116 - 财政年份:2022
- 资助金额:
$ 37.01万 - 项目类别:
Discovery Grants Program - Individual
Targeting apolipoprotein E for Alzheimer's disease therapy.
靶向载脂蛋白 E 治疗阿尔茨海默病。
- 批准号:
22K06460 - 财政年份:2022
- 资助金额:
$ 37.01万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The role of apolipoprotein E in Alzheimer's adaptive immunity
载脂蛋白E在阿尔茨海默病适应性免疫中的作用
- 批准号:
10674878 - 财政年份:2022
- 资助金额:
$ 37.01万 - 项目类别:
Apolipoprotein E and immunometabolism in Alzheimer's disease
载脂蛋白 E 和阿尔茨海默病的免疫代谢
- 批准号:
10388528 - 财政年份:2022
- 资助金额:
$ 37.01万 - 项目类别:
The role of apolipoprotein E in Alzheimer's adaptive immunity
载脂蛋白E在阿尔茨海默病适应性免疫中的作用
- 批准号:
10515592 - 财政年份:2022
- 资助金额:
$ 37.01万 - 项目类别:
Apolipoprotein E and immunometabolism in Alzheimer's disease
载脂蛋白 E 与阿尔茨海默病的免疫代谢
- 批准号:
10644996 - 财政年份:2022
- 资助金额:
$ 37.01万 - 项目类别:
Apolipoprotein E glycosylation and its role in Alzheimer's disease pathogenesis
载脂蛋白E糖基化及其在阿尔茨海默病发病机制中的作用
- 批准号:
10601040 - 财政年份:2021
- 资助金额:
$ 37.01万 - 项目类别:
Impact of cysteine modifications of apolipoprotein E on the remnant lipoprotein metabolism
载脂蛋白E半胱氨酸修饰对残余脂蛋白代谢的影响
- 批准号:
21K07310 - 财政年份:2021
- 资助金额:
$ 37.01万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




